Product Description
Product introduction
Denuril Injection is a medicine used in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It makes the bones strong and reduce the risk of fractures.
Denuril Injection is given by a healthcare professional and should not be self-administered. You should use it regularly and at the same time each day to get maximum benefit from it. Continue using it as recommended by your doctor and complete the dose even if you feel better. To make it more effective, take adequate amount of calcium and vitamin D supplements while on treatment with this medicine.
Some common side effects of this medicine include headache, pain in extremity, musculoskeletal pain, nerve pain, constipation, and rash. Talk to your doctor if any of these side effects does not go away with time or get worse. Your doctor may help with ways to reduce or prevent these symptoms.
To make sure the medicine is safe for you, before taking it, let your doctor know of all the other medicines you are taking. It is important for pregnant and breastfeeding mothers to ask the advice of their doctors before using this medicine.
Uses of Denuril Injection
Side effects of Denuril Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youre worried about them
Advanced Osteoporosis ManagementDenuril Denosumab is a cutting-edge monoclonal antibody formulated for adults facing osteoporosis and bone complications from cancer treatments. Its unique mechanism directly targets bone resorption, helping to boost bone mass and minimize fracture risk. Administered as a convenient, subcutaneous injection twice a year, Denuril simplifies long-term bone health maintenance and supports better outcomes in high-risk patients.
Safe, Preservative-Free SolutionDenuril is carefully formulated without preservatives, ensuring suitability for a wide range of patients, including those requiring sensitive management. The solution remains stable for up to 24 months, provided it is stored in refrigeration. Its clear appearance and controlled dosage in a prefilled syringe offers patients and clinicians peace of mind with each administration.
FAQ's of Denuril Denosumab 60 Mg Injection:
Q: How is Denuril Denosumab 60 mg Injection administered?
A: Denuril is administered by subcutaneous injection, typically into the upper arm, thigh, or abdomen. The standard dose is 60 mg every six months or as directed by your physician.
Q: What conditions does Denuril Denosumab treat?
A: Denuril is recommended for adults to treat osteoporosis, bone loss resulting from hormone ablation in breast or prostate cancer treatment, multiple myeloma, and to prevent skeletal-related complications in patients with bone metastases.
Q: When should I take Denuril Denosumab Injection?
A: Denuril is usually administered once every six months. Your healthcare provider will determine the optimal dosing schedule based on your specific medical needs.
Q: Where should Denuril Denosumab Injection be stored?
A: Store Denuril in its original packaging in a refrigerator at 2C-8C. Do not freeze or expose it to direct sunlight, and keep it out of reach of children.
Q: What are the potential benefits of Denuril Denosumab therapy?
A: Denuril helps increase bone density, reduce the risk of fractures, and lower the likelihood of skeletal-related events in cancer patients with bone involvement, thereby enhancing quality of life.
Q: What are the common side effects of Denuril Denosumab?
A: Common side effects include musculoskeletal pain, higher cholesterol levels, urinary tract infections, and hypocalcemia. Promptly consult your doctor if you experience symptoms of low calcium (e.g., muscle cramps or tingling).
Q: Who should not use Denuril Denosumab Injection?
A: Denuril should not be used by individuals with known hypersensitivity to denosumab or those with low blood calcium levels (hypocalcemia). It is essential to discuss your medical history with your doctor before starting treatment.